SUEMATSU Yasunori

J-GLOBAL         Last updated: May 30, 2019 at 02:41
 
Avatar
Name
SUEMATSU Yasunori
Affiliation
Fukuoka University
Section
Faculty of Medicine, School of Medicine
Research funding number
70716927

Research Interests

 
 

Research Areas

 
 

Published Papers

 
The phosphate binder ferric citrate alters the gut microbiome in ratswith chronic kidney disease.
Lau WL, Vaziri ND, Nunes AC, Comeau AM, Langille MG, England W, Khazaeli M, Suematsu Y, Phan J, Whiteson K
Journal of Pharmacology and Experimental Therapeutics      Oct 2018   [Refereed]
LCZ696 (Sacubitril/valsartan), an Angiotensin-Receptor Neprilysin Inhibitor, Attenuates Cardiac Hypertrophy, Fibrosis and Vasculopathy in a Rat Model of Chronic Kidney Disease.
Suematsu Y, Jing W, Nunes A, Kashyap ML, Khazaeli M, Vaziri ND, Moradi H
Journal of cardiac failure   24(4) 266-275   Apr 2018   [Refereed]
The Current Conditions and Lifestyles of Obese University Students.
Morito N, Suematsu Y, Koyoshi R, Shiga Y, Kuwano T, Iwata A, Fujimi K, Kawamura A, Miura SI
Journal of clinical medicine research   10(3) 240-246   Mar 2018   [Refereed]
Uremic toxins and gut micro biome
Suematsu Y, Shimomura A, Vaziri ND
The Japanese Journal of Nephrology   59 535-544   2017   [Refereed]
LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD.
Jing W, Vaziri ND, Nunes A, Suematsu Y, Farzaneh T, Khazaeli M, Moradi H
American journal of translational research   9(12) 5473-5484   Dec 2017   [Refereed]

Conference Activities & Talks

 
Angiotensin Receptor Neprilysin Inhibitor Preserved Cardiac Function in Atherosclerotic Mouse
Suematsu Y, Tashiro K, Kuwano T, Miura SI
The 2nd JCS Council Forum on Basic CardioVascular Research   Sep 2018   
Anti-atherosclerotis Effects of Improved Apolipoprotein (Apo) A-I Mimetic Peptide
Suematsu Y, Idemoto Y, Kuwano T, Imaizumi S, Uehara Y, Saku K, Miura SI
The 82th Annual Scientific Meeting of the Japanese Circulation Society   Mar 2018   
Newly Fukuoka University ApoA-I Mimetic Peptide, FAMP, improved HDL turnover and anti-atherosclerotic effect compared to conventional FAMP
Suematsu Y, Idemoto Y, Kuwano T, Imaizumi S, Uehara Y, Saku K, Miura SI
1st Asia-Pacific CardioMetabolic Syndrome Congress   Feb 2018   
Improved Apolipoprotein A-I Mimetic Peptide Induced Anti-atherosclerotic Effect
Suematsu Y, Idemoto Y, Kuwano T, Imaizumi S, Uehara Y, Saku K, Miura SI
The 1st JCS Council Forum on Basic CardioVascular Research   Jan 2018   
Serum CETP Activity and Risk of Mortality in Patients with End-stage Renal Disease (ESRD) on Maintenance Hemodialysis
Suematsu Y, Park C, Jing W, Soohoo M, Streja E, Rhee C, Kashyap ML, Vaziri ND, Kalantar-Zadeh K, Moradi H
American Heart Association Scientific Sessions 2017   Nov 2017